Biotech · Private company
Flare Therapeutics Inc.
Track this companyFree. Adds Flare Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- FX-111Phase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- FX-909Phase 1 · Advanced Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- KEYTRUDA ®( Pembrolizumab)Phase 1 · Advanced Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab (KEYTRUDA ®)Phase 1 · Advanced Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study in Patients With Metastatic Castration-Resistant Prostate CancerPHASE1 · RECRUITING · started Jul 1, 2026ClinicalTrials.gov NCT07719361 · fetched Nov 12, 2026
- A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 24, 2023ClinicalTrials.gov NCT05929235 · fetched Nov 12, 2026